World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
19385
World Ranking
2988
National Ranking
114

Emanuele Nicastri publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emanuele Nicastri sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 425 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Emanuele Nicastri D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emanuele Nicastri sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Emanuele Nicastri is affiliated with the Istituto Sperimentale Italiano Lazzaro Spallanzani in Italy. Their research is primarily situated within the field of Medicine, with a significant focus on Infectious Diseases and related subfields. The subfields of study include Infectious Diseases, Epidemiology, Neurology, Molecular Biology, and Public Health, Environmental and Occupational Health.

The scientist has contributed extensively to topics such as COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Long-Term Effects of COVID-19. Additional research interests include Poxvirus research and outbreaks, Herpesvirus infections and treatments, Bacillus and Francisella bacterial research, and Mosquito-borne diseases and control.

Among recent papers authored or co-authored by Emanuele Nicastri are:

  • "Compassionate Use of Remdesivir for Patients with Severe Covid-19" (2020), published in New England Journal of Medicine
  • "First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020" (2020), published in Eurosurveillance
  • "Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022" (2022), published in Eurosurveillance
  • "Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial" (2021), published in Nature Medicine
  • "Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact" (2020), published in Journal of Infection

Frequent co-authors in Nicastri's publications include:

  • Andrea Antinori
  • Enrico Girardi
  • Giuseppe Ippolito
  • Francesco Vaia
  • Alessandra D'Abramo

The scientist's work has appeared predominantly in venues such as the International Journal of Infectious Diseases, bioRxiv (Cold Spring Harbor Laboratory), SSRN Electronic Journal, Journal of Clinical Medicine, and Eurosurveillance.

Nicastri has also contributed to book publications, including a 2022 title titled Chronic Autoimmune Arthritis, Infections and Vaccines published by Frontiers Media.

Best Publications

  • First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

    Gianfranco Spiteri;James Fielding;Michaela Diercke;Christine Campese

  • Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

    Evdoxia Kyriazopoulou;Garyfallia Poulakou;Haralampos Milionis;Simeon Metallidis

  • Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.

    Fabrizio Cantini;Laura Niccoli;Daniela Matarrese;Emanuele Nicastri

  • SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection.

    Francesca Colavita;Daniele Lapa;Fabrizio Carletti;Eleonora Lalle

  • Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016

    Emanuele Nicastri;Concetta Castilletti;Giuseppina Liuzzi;Marco Iannetta

  • CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

    Cristina Mussini;Patrizia Lorenzini;Alessandro Cozzi-Lepri;Giuseppe Lapadula

  • Methicillin-resistant Staphylococcus aureus: the superbug

    Giuseppe Ippolito;Sebastiano Leone;Francesco N. Lauria;Emanuele Nicastri

  • Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).

    Chiara Agrati;Alessandra Sacchi;Veronica Bordoni;Eleonora Cimini

  • Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

    Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.

    Emanuele Andreano;Emanuele Nicastri;Ida Paciello;Piero Pileri

  • 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation.

    Fabrizio Albarello;Elisa Pianura;Federica Di Stefano;Massimo Cristofaro

  • National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.

    Emanuele Nicastri;Nicola Petrosillo;Tommaso Ascoli Bartoli;Luciana Lepore

  • Primary Human Herpesvirus 8 Infection in Immunocompetent Children

    Massimo Andreoni;Loredana Sarmati;Emanuele Nicastri;Gamal El Sawaf

  • Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.

    Laura Falasca;Roberta Nardacci;Daniele Colombo;Eleonora Lalle

  • Surgical site infections in Italian Hospitals: a prospective multicenter study

    Nicola Petrosillo;Cecilia M J Drapeau;Emanuele Nicastri;Lorena Martini

  • Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.

    Rita Carsetti;Salvatore Zaffina;Eva Piano Mortari;Sara Terreri

  • Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses.

    Massimo Arlotti;Paolo Grossi;Federico Pea;Giustino Tomei

  • High Seroprevalence of Antibodies to Human Herpesvirus-8 in Egyptian Children:Evidence of Nonsexual Transmission

    Massimo Andreoni;Gamal El-Sawaf;Giovanni Rezza;Barbara Ensoli

  • Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.

    Fabrizio Cantini;Laura Niccoli;Carlotta Nannini;Daniela Matarrese

  • Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review

    Emanuele Nicastri;Sebastiano Leone;Claudio Angeletti;Lucia Palmisano

  • Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy

    Emanuele Nicastri;Claudio Angeletti;Lucia Palmisano;Loredana Sarmati

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.

    Carla Tortorella;Alessandra Aiello;Claudio Gasperini;Chiara Agrati

Frequent Co-Authors

Giuseppe Ippolito
Giuseppe Ippolito Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Maria Rosaria Capobianchi
Maria Rosaria Capobianchi National Institutes of Health
Nicola Petrosillo
Nicola Petrosillo National Institutes of Health
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Concetta Castilletti
Concetta Castilletti University of Pavia
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Chiara Agrati
Chiara Agrati Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Alimuddin Zumla
Alimuddin Zumla University College London
Enrico Girardi
Enrico Girardi Austrian Academy of Sciences
Vincenzo Vullo
Vincenzo Vullo Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students consider accelerated programs to fast-track their education. For example, the easiest absn to get into offers a streamlined path for those transitioning into nursing, balancing rigorous training with accessible admissions.

Similarly, if you are looking to enter the nursing field swiftly, there are lpn programs with easiest admission requirements that provide foundational clinical skills and patient care experience. These programs serve as stepping stones toward advanced roles in healthcare.

For higher-level practice, many students pursue specialized nursing degrees. The easiest nurse practitioner degree programs feature flexible online curricula designed for working professionals seeking expert clinical training with manageable admissions criteria.

Psychiatric-Mental Health Nurse Practitioner roles are also in demand, and selecting programs with strong clinical support is crucial. The best pmhnp programs online ensure quality clinical placement rates, which is vital for hands-on learning and career readiness in mental health nursing.

Best Scientists Citing Emanuele Nicastri

Trending Scientists

Recently Published Articles